PLAU and neoplasm: The hybrid molecule, originally called EGFATF-PE, and later EGFR-targeted bispecific angiotoxin (eBAT), consists of human EGF, human ATF and a modified Pseudomonas (PE) toxin which induces tumor killing at pico-molar concentrations [176].